|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.410 HKD | 0.00% |
|
-7.66% | -46.92% |
Company Valuation: Cutia Therapeutics
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 3,030 | 2,120 | 1,482 | 756 | - | - |
| Change | - | -30.05% | -30.06% | -49% | - | - |
| Enterprise Value (EV) 1 | 2,471 | 2,055 | 1,469 | 824.7 | 756 | 594.3 |
| Change | - | -16.83% | -28.53% | -43.85% | -8.33% | -21.39% |
| P/E | -1.04x | -4.72x | -3.96x | -4.54x | 16x | 2x |
| PBR | 2.25x | 2.17x | 1.52x | 1.64x | 1.49x | 1.08x |
| PEG | -0x | 0.1x | 0.1x | 0.1x | -0x | 0x |
| Capitalization / Revenue | 22x | 7.58x | 4.41x | 1.17x | 0.64x | 0.43x |
| EV / Revenue | 18x | 7.35x | 4.37x | 1.28x | 0.64x | 0.34x |
| EV / EBITDA | -4.96x | -4.89x | -5.69x | -6.94x | 9.27x | 1.34x |
| EV / EBIT | -4.58x | -4.46x | -4.89x | -5.76x | 14.3x | 2.43x |
| EV / FCF | -5.65x | -4.38x | -4.87x | -2.69x | -26.8x | 9.64x |
| FCF Yield | -17.7% | -22.8% | -20.5% | -37.2% | -3.74% | 10.4% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -9.6 | -1.41 | -1.03 | -0.4581 | 0.1304 | 1.038 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 137.6 | 279.6 | 336.2 | 645.9 | 1,180 | 1,738 |
| EBITDA 1 | -498 | -419.9 | -257.9 | -118.8 | 81.56 | 444.6 |
| EBIT 1 | -538.9 | -461.1 | -300.1 | -143.3 | 52.79 | 244.1 |
| Net income 1 | -1,964 | -433.8 | -340.2 | -145.7 | 44.25 | 330.6 |
| Net Debt 1 | -559.6 | -64.73 | -13.8 | 68.7 | - | -161.7 |
| Reference price 2 | 9.967 | 6.653 | 4.080 | 2.081 | 2.081 | 2.081 |
| Nbr of stocks (in thousands) | 304,024 | 318,588 | 363,368 | 363,368 | - | - |
| Announcement Date | 3/27/24 | 3/24/25 | 3/24/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.54x | 1.28x | -6.94x | - | 112M | |
| 36.25x | 12.94x | 27.18x | 0.55% | 1,089B | |
| 28.59x | 6.53x | 18.09x | 2.01% | 643B | |
| 33.13x | 7.75x | 15.94x | 2.61% | 465B | |
| 20.2x | 4.86x | 12.04x | 2.72% | 359B | |
| 22.65x | 5.84x | 14.57x | 2.74% | 303B | |
| 22.03x | 4.53x | 12.8x | 1.93% | 267B | |
| 14.79x | 5.48x | 11.3x | 3.38% | 226B | |
| 25.81x | 6.73x | 11.86x | 2.57% | 212B | |
| -48.4x | 5.8x | 32.01x | 2.45% | 167B | |
| Average | 15.05x | 6.17x | 14.89x | 2.33% | 373.12B | |
| Weighted average by Cap. | 25.19x | 8.11x | 19.08x | 1.92% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 2487 Stock
- Valuation Cutia Therapeutics
Select your edition
All financial news and data tailored to specific country editions
